Investing.com - Merck KGaA reported on Friday third quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Merck KGaA announced earnings per share of €2.64 on revenue of €5.57B. Analysts polled by Investing.com anticipated EPS of €2.51 on revenue of €5.42B.
Merck KGaA shares are down 23.75% from the beginning of the year, still down 24.77% from its 52 week high of €231.30 set on December 29, 2021. They are under-performing the EUR/USD which is down 0% from the start of the year.
Merck KGaA follows other major Healthcare sector earnings this month
Merck KGaA's report follows an earnings beat by Merck on Friday, who reported EPS of €2.64 on revenue of €5.57B, compared to forecasts EPS of €2.51 on revenue of €5.42B.
Carl Zeiss AG had matched expectations on Friday with fourth quarter EPS of €0.7 on revenue of €477.4M, compared to forecast for EPS of €0.7 on revenue of €477.42M.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar